Navigation Links
First Controlled Large-Scale Intervention Angiotensin Receptor,Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study,Demonstrates Significant Reduction in Blood Pressure and Protection,of Organs with Valsartan

Unprecedented Evidence for the Effectiveness of Hypertension Treatment Valsartan in Preventing Cardiovascular Events in Japanese Patients

TOKYO, April 26, 2007 /Xinhua-PRNewswire/ -- The clinical outcomes of the JIKEI HEART Study, the large-scale clinical trial headed by the Jikei University School of Medicine, was today published in the internationally renowned medical journal The Lancet. The study, involving more than 3,000 patients, is one of the largest cardiovascular intervention trials conducted in a Japanese population under realistic clinical settings. It also is the first large- scale study evaluating the benefits of the ARB, valsartan, in Japanese patients.

In the study, valsartan was added to conventional therapy to control blood pressure and protect against cardiovascular events and stroke. The results showed significant benefit with the use of valsartan, including a 39% decrease in cardiovascular events and a 40% decrease in stroke compared to conventional non-ARB therapy. Initiated in 2001, the JIKEI HEART Study was terminated earlier than anticipated at the request of the Data and Safety Monitoring Board due to superior outcomes for the valsartan group over the control group.

"Treatment of hypertension needs to account for blood pressure control but also should take into account the prevention of cardiovascular diseases over an extended period," said Seibu Mochizuki, M.D., PhD, formerly of Jikei University School of Medicine, chief investigator of the JIKEI HEART Study. "In the JIKEI HEART Study we accomplished both -- we achieved the lowest blood pressure value ever set in a morbidity/mortality outcomes trial and saw tremendous benefit for the valsartan arm in reducing the risk of cardiovascular events as well as stroke. Because of this, valsartan will play an important role in treating hypertension as it has been shown to lower blood pressure while being highly protective of end o
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model

Post Your Comments:
(Date:11/25/2009)... ,, CHAPELHILL,N.C.,Nov.25/PRNewswire/--Cemp...Fernandes,presidentandchiefexecutiveofficer,willpr...ceat8:50a.m.EST,December1,2009,atTheNewYorkPalaceH...wofthecompany,stwoleadingantibioticclinicalprogram...MRSA. ,, AboutCempraPharmaceuticals ,, Fou...
(Date:11/25/2009)... ,, NEWYORK,Nov.25/PRNewswire/--Reportlinker...leinitscatalogue: ,, IntranasalDrugDelivery-US....com/p0164267/Intranasal-Drug-Delivery---US-Market...eliverymarketiswitnessinganexpansionoftherapeutica...peuticdrugstothedeliveryofsystemictherapeuticdrugs...
(Date:11/25/2009)... ,, FRAMINGHAM,Mass.andSYDNEY,Nov.25/PRNewsw...: HTWR ;ASX:HIN),aleadinginnovatorandproviderofles...esrevolutionizingthetreatmentofadvancedheartfailur...resentationatthe21stAnnualPiperJaffrayHealthCareCo...onferenceisbeingheldattheNewYorkPalaceHotel,Decemb...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Cancer Related Educational Video Sharing and Interactive Community Launches Online 48855 1Cancer Related Educational Video Sharing and Interactive Community Launches Online 48855 2Cancer Related Educational Video Sharing and Interactive Community Launches Online 48855 3Frost 26 Sullivan Recognizes Singulex for Erenna 28R 29 Immunoassay System 48854 1Frost 26 Sullivan Recognizes Singulex for Erenna 28R 29 Immunoassay System 48854 2Frost 26 Sullivan Recognizes Singulex for Erenna 28R 29 Immunoassay System 48854 3Frost 26 Sullivan Recognizes Singulex for Erenna 28R 29 Immunoassay System 48854 4New York State Department of Transportation and American Lung Association in New York Announce Commit to Cleaner Air Week 48851 1New York State Department of Transportation and American Lung Association in New York Announce Commit to Cleaner Air Week 48851 2New York State Department of Transportation and American Lung Association in New York Announce Commit to Cleaner Air Week 48851 3
... Calif.--(BUSINESS WIRE)--Jun 1, 2007 - Arrowhead ... that interim Phase I data,has been published in t...ceedings (ASCO) (Abstract ID 32638). The data are ... evaluate the safety,tolerability, and pharmacoki...101, in patients with inoperable or metastatic,tum...
... IL -- CytImmune, a clinical stage nanomedicine co...tion of,multifunctional, tumor-targeted therapies ...ican Society of Clinical Oncology (ASCO),Annual me...f a,Phase 1 Clinical Trial of CYT-6901," announced...te conducted and CytImmune Sciences,sponsored Phas...
Other Medicine Technology:Arrowhead Subsidiary, Insert, Publishes Interim Phase I Data from,Human Clinical Trials for New Cancer Drug 2Arrowhead Subsidiary, Insert, Publishes Interim Phase I Data from,Human Clinical Trials for New Cancer Drug 3CytImmune Presents Positive CYT-6019 Data During the American,Society of Clinical Oncology Annual Meeting in Chicago 2CytImmune Presents Positive CYT-6019 Data During the American,Society of Clinical Oncology Annual Meeting in Chicago 3
(Date:11/27/2009)...hree new interactive anatomy education apps from M...nd health sciences learning opportunities for iPho...m, NC (Vocus) November 27, 2009 -- Modality, Inc....ivision of Wolters Kluwer Health, today announced ...ps on the App Store. Clemente’s Anatomy, Roh...
(Date:11/26/2009)...27/PRNewswire/--ThediabetespopulationintheUnitedSt...icalspendingonthediseaseisprojectedtohit$336billio...dintheDecemberissueof DiabetesCare .TheNational Ch...ordisk,commissionedtheanalysisbyateamfromtheUniver...berofAmericanslivingwithdiabeteswillrisefrom23.7mi...
(Date:11/26/2009)...rug tetrathiomolybdate (TM) has been shown in stud...ease, a disease caused by an overload of copper, a... Very little, however, is known about how the drug... by Northwestern University researchers now has pr...tructure of TM bound to copper-loaded metallochape...
(Date:11/26/2009)...en on an emotional rollercoaster, study finds , ...ll it the fear factor meets the jubilant sports fa...pecially those who root for the winning team -- en...ntested match and victory was in doubt, producing ...hat this Thanksgiving weekend as you,re glued to t...
(Date:11/26/2009)...r. David Kim of the Live Life Again Center, a prac...one of a growing number of physicians who are tak...o connect with individuals who are interested in s...ity. Dr. Kim is utilizing Facebook to share before...ce with the community. , ...
Breaking Medicine News(10 mins):Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3
...etitive Nature of Industry, WASHINGTON, Feb. 13 ...on, today released an important new study that,dem...s in the highly,competitive medical technology sec...relatively small and constant share of total natio...
... Multi-Specialty Group Automates and Connects Phys...gement, CHICAGO and MANKATO, Minn., Feb. 13 ,Alls... connectivity and,information solutions that physi...e clinical tasks for their 113,multi-specialty phy...
...ds most older men will die of other causes , ... the largest studies of its kind concludes that mo...rten their survival odds if they adopt a "wait-and... the researchers found. , "Many elderly men with l...
... software could enable Britains swimmers to improv... effectively than previously possible and so help...ture. , The software provides instant, in-depth ...heir momentum to travel through the water. As well...
...veryday Lives of Eight Families Living with Autism...t the,U.S. television premiere of Lauren Thierry,s...ich has been designated World Autism Awareness Day...uggling to raise children with autism. Autism Ever...
... who eat a diet low in fat and red meat but high i...l in moderation may not just be doing their hearts...thy diet may also be good for the prostate., Speci... frequent and painful urination that affects about...
Other Medicine News:Health News:New Study Finds Slow Rate of Growth in Overall Medical Technology Prices 2Health News:Mankato Clinic Selects Allscripts Electronic Health Record 2Health News:Mankato Clinic Selects Allscripts Electronic Health Record 3Health News:Mankato Clinic Selects Allscripts Electronic Health Record 4Health News:Many Prostate Cancers Will Not Need Treatment 2Health News:Many Prostate Cancers Will Not Need Treatment 3Health News:Gliding to gold -- world-beating software could boost British swimming 2Health News:Sundance Channel to Premiere Documentary Autism Every Day on World Autism Awareness Day, April 2nd at 8:00pm et/pt 2Health News:What's good for the heart may be good for the prostate 2Health News:What's good for the heart may be good for the prostate 3
...CI® Oximetry Data Management Program is a Wind...the FingerPrint® Sleep Hand-Held Pulse Oximete...9 Interface Cable, it rapidly downloads informatio... validation, and/or related studies, and assists i...
ImmunoWELL Measles (Recombinant) IgG Test
...mmunoWELL EBNA IgG Test is an ELISA method for the...Barr Virus nuclear antigen-1 (EBNA-1) in human ser...with other testing such as the EBV viral capsid Ig...ophile tests, the results can serve as an aid in t...
ImmunoDOT Borrelia (Lyme) Test (with Recombinant Protein)
Medicine Products: